Lunai Bioworks Inc. Current Liabilities
Lunai Bioworks Inc. (LNAI) had Current Liabilities of $19.28 million as of 2026-03-31, per its 10-Q filed 2026-05-15.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:LiabilitiesCurrent · last filed 2026-05-15
- 2026-03-31: Liabilities, Current $19.28M.
- 2025-12-31: Liabilities, Current $20.00M.
- 2025-09-30: Liabilities, Current $19.72M.
- 2025-06-30: Liabilities, Current $29.16M.
| Period end | Liabilities, Current | Liabilities, Current as first filed |
|---|---|---|
| 2026-03-31 | $19.28M 10-Q · filed 2026-05-15 | |
| 2025-12-31 | $20.00M 10-Q · filed 2026-02-17 | |
| 2025-09-30 | $19.72M 10-Q · filed 2025-11-14 | |
| 2025-06-30 | $29.16M 10-Q · filed 2026-05-15 | |
| 2025-03-31 | $28.84M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | $28.61M 10-Q · filed 2025-02-19 | |
| 2024-09-30 | $23.04M 10-Q/A · filed 2025-02-19 | |
| 2024-06-30 | $30.31M 10-K · filed 2025-09-29 | |
| 2024-03-31 | $20.87M 10-Q/A · filed 2025-02-19 | |
| 2023-12-31 | $13.76M 10-Q · filed 2024-02-14 | |
| 2023-09-30 | $10.10M 10-Q · filed 2023-11-14 | |
| 2023-06-30 | $11.02M 10-Q/A · filed 2025-02-19 | |
| 2023-03-31 | $11.77M 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $11.29M 10-Q · filed 2023-03-09 | |
| 2022-09-30 | $7.16M 10-Q · filed 2023-03-07 | |
| 2022-06-30 | $6.45M 10-K · filed 2023-10-02 | |
| 2022-03-31 | $7.51M 10-Q · filed 2022-05-13 | |
| 2021-12-31 | $6.20M 10-Q · filed 2022-02-14 | |
| 2021-09-30 | $1.21M 10-Q · filed 2021-11-15 | |
| 2021-06-30 | $1.89M 10-K · filed 2023-02-27 | |
| 2021-03-31 | $1.41M 10-Q · filed 2021-05-17 | |
| 2020-12-31 | $1.56M 10-Q · filed 2021-02-16 | |
| 2020-09-30 | $832.18K 10-Q · filed 2020-11-12 | |
| 2020-06-30 | $1.33M 10-K · filed 2021-09-24 | |
| 2020-03-31 | $971.27K 10-Q · filed 2020-05-11 | |
| 2019-12-31 | $1.09M 10-Q · filed 2020-02-10 | |
| 2019-09-30 | $1.30M 10-Q · filed 2019-11-13 | |
| 2019-06-30 | $1.11M 10-K · filed 2020-09-23 | |
| 2019-03-31 | $1.52M 10-Q · filed 2019-05-16 | |
| 2018-12-31 | $1.64M 10-Q · filed 2019-02-13 | |
| 2018-09-30 | $784.88K 10-Q · filed 2018-11-14 | |
| 2018-06-30 | $873.72K 10-K · filed 2019-09-30 | |
| 2018-03-31 | $906.07K 10-Q · filed 2018-05-15 | |
| 2017-12-31 | $5.97M 10-Q · filed 2018-02-09 | |
| 2017-09-30 | $951.45K 10-Q · filed 2017-11-20 | |
| 2017-06-30 | $2.99M 10-K · filed 2018-10-01 | |
| 2017-03-31 | $1.99M 10-Q · filed 2017-05-15 | |
| 2016-12-31 | $1.41M 10-Q · filed 2017-02-14 | |
| 2016-09-30 | $1.41M 10-Q · filed 2016-11-14 | |
| 2016-06-30 | $1.51M 10-K · filed 2017-11-20 | |
| 2016-03-31 | $1.04M 10-Q · filed 2016-05-13 | |
| 2015-12-31 | $893.91K 10-Q · filed 2016-02-12 | |
| 2015-09-30 | $1.01M 10-Q · filed 2015-11-13 | |
| 2015-06-30 | $995.74K 10-K · filed 2016-09-28 | |
| 2015-03-31 | $971.97K 10-Q · filed 2015-05-13 | |
| 2014-12-31 | $1.76M 10-KT · filed 2015-09-28 | |
| 2014-09-30 | $4.93M 10-Q · filed 2014-11-13 | |
| 2014-06-30 | $3.35M 10-Q · filed 2014-08-14 | |
| 2014-03-31 | $3.10M 10-Q · filed 2014-05-14 | |
| 2013-12-31 | $2.13M 10-KT · filed 2015-09-28 | $79.25K 10-Q · filed 2014-02-11 |
| 2013-09-30 | $83.81K 10-Q · filed 2013-11-15 | |
| 2013-06-30 | $67.62K 10-Q · filed 2013-08-15 | |
| 2013-03-31 | $71.23K 10-Q · filed 2014-02-11 | |
| 2012-12-31 | $2.09M 10-Q · filed 2014-08-14 | $54.94K 10-Q · filed 2013-02-14 |
| 2012-09-30 | $47.26K 10-Q · filed 2012-11-14 | |
| 2012-06-30 | $38.23K 10-Q · filed 2012-08-20 | |
| 2012-03-31 | $27.23K 10-K · filed 2013-07-16 | |
| 2011-12-31 | $22.61K 10-Q · filed 2012-02-21 | |
| 2011-09-30 | $18.81K 10-Q · filed 2011-11-25 | |
| 2011-03-31 | $8.73K 10-K · filed 2012-07-17 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |
| Verrica Pharmaceuticals Inc. (VRCA) | United States | $0.076B | -3.39 |